An excerpt from an open letter sent to VeriChip Corporation and signed by James Baranski, CEO of the National Stroke Association, states, "Personal Health Records, including implantable RFID microchips such as VeriMed, could play a critical role in assisting medical professionals in delivering appropriate stroke treatment promptly, leading to better patient outcomes."
The VeriMed Patient Identification System is comprised of a hand held radio frequency identification (RFID) scanner, an implantable RFID microchip and a secure patient database. The combinations of these different devices and systems is being used to help rapidly identify and provide access to important health information on participating patients who arrive at an emergency department unconscious, delirious or unable to communicate.
The implantable RFID system is the only system of its design that has been cleared by the United States Food and Drug Administration for use in people.
The National Stroke Association is the only national organization in the United States that focuses 100% of its efforts on stroke. Established in 1984, the NSA has become a leading national resource on stroke and the driving force behind efforts to improve stroke prevention, treatment and rehabilitation.
